{"id":2659,"date":"2019-11-29T18:18:00","date_gmt":"2019-11-29T18:18:00","guid":{"rendered":"http:\/\/staging.grindeks.eu\/grindeks-profit-in-the-first-nine-months-of-2019-increases-by-17-and-reaches-8-9-million-euro\/"},"modified":"2022-07-04T18:23:26","modified_gmt":"2022-07-04T18:23:26","slug":"grindeks-profit-in-the-first-nine-months-of-2019-increases-by-17-and-reaches-8-9-million-euro","status":"publish","type":"post","link":"https:\/\/grindeks.com\/lv\/grindeks-profit-in-the-first-nine-months-of-2019-increases-by-17-and-reaches-8-9-million-euro\/","title":{"rendered":"2019. gada devi\u0146os m\u0113ne\u0161os Grindeks pe\u013c\u0146a pieaug par 17% un sasniedz 8,9 milj. eiro"},"content":{"rendered":"\n

\u0160odien, 28. novembr\u012b, akciju sabiedr\u012bbas Grindeks \u201eNasdaq Riga\u201d iesniegtie 2019. gada devi\u0146u m\u0113ne\u0161u nerevid\u0113tie konsolid\u0113tie finan\u0161u p\u0101rskati liecina, ka koncerna pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tes sabiedr\u012bbas akcion\u0101riem, ir sasniegusi 8,9 milj. eiro. Sal\u012bdzinot ar 2018. gada devi\u0146iem m\u0113ne\u0161iem, pe\u013c\u0146a ir palielin\u0101jusies par 1,3 milj. eiro vai par 17%. Koncerna apgroz\u012bjums 2019. gada devi\u0146os m\u0113ne\u0161os bija 106,6 milj. eiro, kas ir par 4,1 milj. eiro vai par 4% vair\u0101k nek\u0101 2018. gada devi\u0146os m\u0113ne\u0161os.<\/p>\n\n\n\n

AS Grindeks valdes priek\u0161s\u0113d\u0113t\u0101js Juris Bundulis: \u201e2019. gada devi\u0146os m\u0113ne\u0161os esam paaugstin\u0101ju\u0161i produktivit\u0101ti, uzlaboju\u0161i koncerna neto pe\u013c\u0146as rentabilit\u0101ti un sasniegu\u0161i 8,9 milj. eiro pe\u013c\u0146u. Tas uz\u0146\u0113muma att\u012bst\u012bbai dod pozit\u012bvu efektu, kuru es uzskatu par iek\u0161\u0113j\u0101 sp\u0113ka apliecin\u0101jumu. Raugoties uz farm\u0101cijas industrijas s\u012bvo konkurenci, m\u016bsu ilgtsp\u0113jas biznesa model\u012b ar\u012b turpm\u0101k b\u016bs svar\u012bga uz\u0146\u0113muma iek\u0161\u0113j\u0101s vides pilnveide, lai pied\u0101v\u0101tu pacientiem jaunus, kompleksus risin\u0101jumus vi\u0146u vesel\u012bbas vajadz\u012bbu apmierin\u0101\u0161anai un sasniegtu teicamus biznesa r\u0101d\u012bt\u0101jus.\u201d<\/em><\/p>\n\n\n\n

2019. gada devi\u0146os m\u0113ne\u0161os Koncerna sara\u017eot\u0101 produkcija eksport\u0113ta uz 75 pasaules valst\u012bm kopum\u0101 par 99,6 milj. eiro, kas ir par 4,3 milj. eiro vai par 5% vair\u0101k nek\u0101 2018. gada devi\u0146os m\u0113ne\u0161os.<\/p>\n\n\n\n

Grindeks gatavo z\u0101\u013cu p\u0101rdo\u0161anas apjoms 2019. gada devi\u0146os m\u0113ne\u0161os bija 98,0 milj. eiro un ir palielin\u0101jies, sal\u012bdzinot ar 2018. gada devi\u0146iem m\u0113ne\u0161iem, par 2,2 milj. eiro. P\u0101rdo\u0161anas apjoms Krievij\u0101, p\u0101r\u0113j\u0101s NVS valst\u012bs un Gruzij\u0101 2019. gada devi\u0146os m\u0113ne\u0161os veidoja 61,4 milj. eiro, kas ir par 0,4 milj. eiro vai par 1% vair\u0101k nek\u0101 2018. gada devi\u0146os m\u0113ne\u0161os. Sal\u012bdzinot ar 2018. gada devi\u0146iem m\u0113ne\u0161iem, 2019. gada devi\u0146os m\u0113ne\u0161os noz\u012bm\u012bgs p\u0101rdo\u0161anas apjoma pieaugums sasniegts \u2013 Turkmenist\u0101n\u0101 par 51%, Baltkrievij\u0101 par 28% un Gruzij\u0101 par 23%.
Gatavo z\u0101\u013cu p\u0101rdo\u0161anas apjoms Eiropas Savien\u012bbas valst\u012bs 2019. gada devi\u0146os m\u0113ne\u0161os sasniedza 34,0 milj. eiro, kas ir par 1,7 milj. eiro vai 5% vair\u0101k nek\u0101 2018. gada devi\u0146os m\u0113ne\u0161os. P\u0101rdo\u0161anas apjoms 2019. gada devi\u0146os m\u0113ne\u0161os, sal\u012bdzinot ar 2018. gada devi\u0146iem m\u0113ne\u0161iem, Francij\u0101 un Zviedrij\u0101 ir palielin\u0101jies 2 reizes, bet \u010cehij\u0101 par 38%.<\/p>\n\n\n\n

2019. gada devi\u0146os m\u0113ne\u0161os akt\u012bvo farmaceitisko vielu p\u0101rdo\u0161anas apjoms sasniedza 6,5 milj. eiro, kas ir par 0,8 milj. eiro vai 14% vair\u0101k nek\u0101 2018. gada devi\u0146os m\u0113ne\u0161os. \u0160aj\u0101 period\u0101 liel\u0101kais Grindeks akt\u012bvo farmaceitisko vielu eksports tika veikts uz ES valst\u012bm, Jap\u0101nu, Kan\u0101du un Austr\u0101liju. Grindeks piepras\u012bt\u0101k\u0101s akt\u012bv\u0101s farmaceitisk\u0101s vielas 2019. gada devi\u0146os m\u0113ne\u0161os bija deksmedetomid\u012bns, ksilaz\u012bns un oksitoc\u012bns.<\/p>\n","protected":false},"excerpt":{"rendered":"

\u0160odien, 28. novembr\u012b, akciju sabiedr\u012bbas Grindeks \u201eNasdaq Riga\u201d iesniegtie 2019. gada devi\u0146u m\u0113ne\u0161u nerevid\u0113tie konsolid\u0113tie finan\u0161u p\u0101rskati liecina, ka koncerna pe\u013c\u0146a, kas attiecin\u0101ma uz m\u0101tes…<\/p>\n","protected":false},"author":3,"featured_media":2588,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-2659","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-jaunums"],"acf":[],"_links":{"self":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/2659","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/comments?post=2659"}],"version-history":[{"count":0,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/posts\/2659\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media\/2588"}],"wp:attachment":[{"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/media?parent=2659"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/categories?post=2659"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/grindeks.com\/lv\/wp-json\/wp\/v2\/tags?post=2659"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}